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SPECIFICATION 
E-Learning program and Learning Management System for post graduate training in 
Radiopharmacy 
1 Scope 
1.1 General 
1.1.1 This Specification describes the requirements for an e-Learning program and a Learning 
Management System, hereinafter referred to as the “System”. The System is intended to 
deliver in English, post graduate programs, i.e. Master of Science and Postgraduate Diploma 
in Radiopharmacy for radiopharmacists and radiopharmacy technologists respectively (the 
“Program”). 
1.1.2 The System is intended to be used by academic institutions, students, student supervisors 
based in IAEA’s member States and the IAEA Technical Officers, hereinafter referred to as 
the “End Users”. 
1.2 Content of the Program  
1.2.1 It is expected that the proposed Program is based on ‘Blended learning’ techniques, i.e. an 
education program that combines online digital media with traditional classroom methods 
such as workshops, maintenance of daily practical log books and online and face-to-face 
assessments. 
1.2.2 The Program shall fully describe curricula and teaching methodology to be used (total  
duration of the course, learning objectives and outcomes for the course and for each 
module, pre-requisites, hours of study expected to cover each module, recommended 
assessment  methodology, supplementary bibliography, videos or animations to be 
produced and face to face practical exercises to be ensured.  
1.2.3 The Program shall be designed based on the Radiopharmacy Syllabus and applicable 
guidance documents published by IAEA (hereto attached as Annex 1). 
1.3 Required Services 
1.3.1 The Supplier is requested to provide a comprehensive solution including the development, 
testing and installation of the System. 
1.3.2 The Supplier shall test all functionalities of the System at its own institution or at another 
institution with IAEA’s agreement. The System shall be available for demonstration and 
verification of functionalities by the IAEA. 
1.3.3 The System shall be installed at the following academic institutions selected by the IAEA: 
Supplier site for the testing and acceptance (phase 1), in addition to an African academic 
institution (Kenya or Tanzania) for the installation and training (phase 2). 
2 Applicable Documents 
2.1.1 The Syllabus contents shall include guidance documents published by the professional 
organisations such as the European Association of Nuclear Medicine (EANM), and the 
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International Society of Radiolabeling of Blood Elements (ISORBE). Other relevant 
Documents are listed in Annex 1, Section 3. 
3 Definitions, Acronyms, and Abbreviations 
The following definitions, acronyms, and abbreviations shall apply throughout this Specification 
unless defined otherwise hereinafter: 
e-L (e-Learning 
program) 
Post graduate program delivered with the support of Information and 
Communication Technology (ICT) 
Blended learning Blended learning is a teaching methodology that combines usage of online 
digital media with traditional classroom methods 
LMS Learning Management System 
e-L and LMS The System 
MSc Master of Science for Radiopharmacists 
PGD Post Graduate Diploma for Radiopharmacy Technologists 
ECTS European Credit Transfer and Accumulation System 
WHO World Health Organisation 
EANM European Association of Nuclear Medicine 
ISORBE International Society for Radiolabeling of Blood Elements 
SCORM Sharable Content Object Reference Model 
4 Requirements 
4.1 Functional and Performance Requirements 
The System shall meet the following functional and performance requirements: 
4.1.1 The Supplier shall review and update the proposed Syllabus (Annex 1) and practical 
experience requirements for MSc and PGD courses. 
4.1.2 The System shall provide criteria for admission for the MSc and PGD programs.  
4.1.3 The Supplier shall provide an online examination for admission of students for MSc and PGD 
programs. The System shall provide a mechanism for registering students on the post 
graduate program and for monitoring and assessing their progress during the course. The 
System shall provide ‘pre-online-assessment’ identity checking procedure for the 
participating students during the course.  
4.1.4 The System shall be maintained by the Supplier.  
4.1.5 The e-Learning program shall contain developed lecture materials as a series of 
presentations prepared by a team of subject matter experts, academics and practicing 
professionals in the field based on the Syllabus developed by the IAEA Experts and 
subsequently reviewed and updated by the Supplier.   
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4.1.6 The e-Learning program shall produce and incorporate explanatory videos of relevant 
aspects of radiopharmacy practices. 
4.1.7 Based on the lecture materials, the e-Learning program shall provide an online examination 
such as Multiple Choice Questions (MCQs) and written exams. 
4.1.8 The e-Learning program shall provide procedures for assessment and record keeping of 
examinations. 
4.1.9 The e-Learning materials shall meet the applicable postgraduate training requirements in 
terms of contents and number of hours as required by the applicable ECTS academic 
standards. 
4.1.10 The e-Learning material shall be developed using software package such as Adobe Captivate 
or similar authoring tools. The produced modules shall fulfil SCORM standards. The e-
Learning program shall be delivered based on free software systems such as ‘Moodle’ in its 
latest tested version. 
4.1.11 The e-Learning program developed shall be accessible via desktop, laptop, tablets and other 
mobile devices.  
4.1.12 The e-Learning program shall provide a suitable “mobile App” as interface for tablet 
computers or mobile communication devices such as smart phones.  
4.1.13 The e-Learning program shall be developed, tested and delivered as a product within a 
period of 18 months, including a pilot testing of the final product. 
4.1.14 The supplier shall provide and maintain during the period of development the necessary 
software and hardware servers (physical servers or virtual machines in cloud space) to store 
and test the e-Learning material developed with necessary backup. The Supplier shall take 
the responsibility of the operating system at OS level, system level, application level and 
users support level. 
4.2 Technical Requirements 
The System shall meet the following technical requirements: 
4.2.1 The Supplier shall provide the required server capacity to host, test and deliver the e-
Learning program. 
4.2.2 The hardware and software shall be maintained fully during the development phase and 
during subsequent trial period. 
4.2.3 The e-Learning program shall have a built-in biannual review schedule of its contents and 
delivery system. 
4.2.4 The Supplier shall develop necessary manuals and technical documentation for maintenance 
of the System and implementation of the e-Learning program. 
4.3 Other Requirements (Intellectual Property Rights) 
4.3.1 The e-Learning material shall remain property of the IAEA, available to be hosted at the IAEA 
selected academic institutions to deliver e-Learning (Supplier and Kenya or Tanzania).  
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4.3.2 The Supplier shall be required to provide online technical assistance for installation and 
running of the system at the selected academic institutions.  
4.3.3 All source codes and instructions developed for setting up and for editing/reviewing the e-
Learning program along with the associated Learning Management System software shall be 
property of the IAEA.  
4.3.4 All above mentioned source codes shall be transferred to the IAEA. Documents containing 
technical background information to support migration of the source codes shall be 
provided by the Supplier. 
5 Quality Requirements 
The e-Learning program shall meet the Learning Management System applicable standards as listed 
under 4.1. 
6 Testing and Acceptance (Phase 1) 
6.1 The System shall be tested for required specifications by an IAEA expert at the Supplier site. 
6.2 The results of the testing of the System shall be documented by the IAEA expert in an 
acceptance protocol that shall be signed off by the Supplier.  
6.3 The Supplier shall be responsible for all costs related to such test, except for the expert 
related costs. 
7 Installation and Training (Phase 2) 
7.1 The Supplier shall install the e-Learning program on an independent server in an African 
academic institution (Kenya or Tanzania) and shall train during at least three (3) days, two (2) 
designated staff members of that institution in all operations of the System.   
8 Deliverable Items 
The following items shall be delivered:  
8.1 Revised syllabi for the MSc and PGD programs meeting ECTS requirements. 
8.2 A comprehensive e-Learning program, as specified above, meeting the revised syllabi 
requirements, as described above. 
8.3 Videos covering practical aspects of daily radiopharmacy work in a clinical set up to support 
the e-Learning syllabus, as listed in Annex 1, Section 2. 
8.4 All source codes and instructions developed for setting up, operating, editing, reviewing of 
course materials and the Learning Management System.  
8.5 Documents containing technical instructions to support the migration and transfer of e-
learning course materials and Learning Management System to any other academic institute. 
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Annex 1:  Syllabus and Applicable Documents 
1 Syllabus topics for production of e-Learning materials 
Radiopharmacy 
Masters Course 
Topics/Lessons Competencies to be achieved 
Basic (Applied) 
Pharmacy   
1. Basic Pharmaceutical Technology 
2. Good Manufacturing Practice (GMP) 
3. Sterile Manufacture  
4. Pharmaceutical microbiology  
5. Parenteral Preparations  
6. Formulation and Packaging  
7. Pharmaceutical Analysis  
8. Pharmacopoeia monographs  
9. Quality Assurance and Product 
Performance  
10. Quality Control Procedures  
11. Stability and Shelf Life  
12. Regulations and Legal Aspects  
13. Marketing Authorizations  
14. Responsibilities of Personnel 
Be able to identify and plan 
pharmaceutical technology 
requirements for setting up a 
radiopharmacy service. 
Be able to plan and implement 
GMP and aseptic techniques in 
radiopharmacy. 
Be able to plan and implement 
Quality Assurance in 
Radiopharmacy. 
Be able to understand and apply 
national and international 
pharmaceutical and radiation 
regulatory requirements and 
quality standards to the 
radiopharmacy operations 
undertaken. 
Be responsible for manufacturing 
or quality control of 
radiopharmacy operations. 
 
Radiopharmaceutical 
Chemistry 
1. Basics on radiochemistry, 
Radiopharmaceutical Definition, Essential 
Properties of Radiopharmaceuticals – 
physical, chemical, biological, 
pharmaceutical properties 
2. Production of Radionuclides - Nuclear 
reactor, Cyclotron, Radionuclide 
generators  
3. Radiometal pharmaceuticals I - 
Radiopharmaceutical chemistry of  
99mTc-Radiopharmaceuticals, 
4. Radiometal pharmaceuticals II - 
Radiopharmaceutical chemistry: Re, Cu, 
In, Ga, Y. 
5. Organic radiopharmaceuticals I - 
Introduction to PET, 11C-
radiopharmaceuticals 
Develop understanding of  
radiochemistry principles.  
Develop through understanding 
of radionuclide production 
processes. 
Develop through understanding 
of metallic and organic 
radiopharmaceutical 
radiolabeling techniques. 
Develop understanding of 
radiopharmaceutical localisation 
and radiopharmacology. 
Develop through understanding 
of diagnostic, therapeutic and 
biological radiopharmaceuticals. 
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6. Organic radiopharmaceuticals II 
Radiofluorinations - 18F-
radiopharmaceuticals 
7. Organic radiopharmaceuticals III -  
Radiohalogenations: Br, I, At 
8. Methods of radiolabeling, Specific 
factors, Kits 
9. Basic Radiopharmacology – 
Mechanisms of Localization of 
Radiopharmaceuticals,  Pharmacology 
Versus Mechanisms of Localization, 
Biological Basis of Distribution of 
Radiopharmaceuticals 
10. Radiopharmaceuticals for Diagnostic 
Purpose 
11. Radiopharmaceuticals for 
Therapeutical Purpose 
12. Radiolabeled Blood Cells/elements. 
Develop through understanding 
of radiolabeling techniques and 
associated quality control. 
 
Nuclear Physics, 
Radiation Safety & 
Regulations 
1. Structure and Properties of Atoms 
2. Radioactivity, Radiation and 
Radioactive Decay, Decay schemes of 
Radionuclides Load in Nuclear Medicine, 
Units of Radiation Measurement 
3. Radiation Calculations - Radioactivity 
Measurement and Counting Statistics, 
Radiopharmaceutical Preparation and 
Dispensing Calculations, Dosimetry, 
Quality Assurance Calculations 
4. Interactions of Radiation with Matter 
5. Instruments for Radiation Detection 
and Measurement 
6. Health Physics Equations and Use 
7. Principles of Radiation Protection 
8. Occupational and Non-Occupational 
Exposure Radiation Protection Guides 
9. Personnel Monitoring and Precautions 
10.  Area Monitoring (Personnel and 
Work Environment) 
11. Radioactive Packages and Sources 
12. Radioactive and Biohazardous Waste 
Disposal Methods 
13. Radiation Safety, Radiation Accidents 
14. Regulations – National, EU, IAEA 
standards 
Develop through understanding 
of basic nuclear physics, 
interaction of ionising radiation 
with matter, instrumentation for 
radiation detection, radiation 
protection principles and 
practice. 
Develop through understanding 
of national and international 
radiation protection regulations 
as applicable to staff, patients, 
members of public and the 
environment.  
Develop through understanding 
of radiation regulations as 
applied to the transport of 
radioactive materials. 
Develop through understanding 
of radiation incident 
management as applicable to 
radiopharmacy operations. 
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Radiopharmacology 1. Medical terminology used in 
radiopharmacy 
2. Basic principles of pharmacology 
3. LADME process 
4. Ideal qualities of radiopharmaceuticals, 
methods of radiolabeling 
5. Principles of mechanism of localization 
of radiopharmaceuticals 
6. The principles of imaging procedures 
using radiopharmaceuticals 
7. The principles of therapeutic 
procedures using radiopharmaceuticals 
8. Dosimetric aspects of 
radiopharmaceutical applications 
9. New radiopharmaceuticals: from 
molecule to man 
Develop through understanding 
of radiopharmacology principles 
including radiation dosimetry as 
applicable to the diagnostic and 
therapeutic 
radiopharmaceuticals. 
Develop through understanding 
of processes involved in 
developing new 
radiopharmaceuticals.  
 
Animal models, disease 
models, animal 
protection regulations, 
ethical issues 
1. Introduction of importance to use 
animal model in the research 
2. Creation of appropriate cell-based and 
animal models of pathology and the 
clinical translation of the optimized 
concepts to help detect disease and 
therapeutic response in people 
3. Ethics of animal experimentation  
4. Welfare and experimental procedures 
5. Preparation protocol (introduction) 
6. Introduction to micro-surgery 
techniques. 
7. Invasive and/or semi-automated 
chronic blood sampling techniques in 
rodents 
8. Injection and administration 
techniques - administration of 
substances, suturing 
9. Practical handling & restraining tech. 
10. Guidelines for a safe transportation of 
laboratory animals around the world 
11. Different caging systems for small 
laboratory rodents 
12. Demonstration experimental 
techniques, collection of body fluids 
13. Cryopreservation 
14. Occupational health & safety program 
15. Alternatives to animal procedures 
16. Breeding of laboratory rodents 
17. Anaesthesia 
18. Methods of humane euthanasia 
To develop through 
understanding of use of animals 
for clinical research in all aspects 
such as regulatory, ethical and 
practical.  
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19. Analgesia and per‐operative care 
20. Statistics + methodology 
21. Cost‐Benefit analysis 
Radiation Biology 1. Interaction of Ionizing Radiation with 
Matter - Types of radiation, Interactions 
of Radiation with Emphasis on Biological 
Systems, Units of Energy Transfer,  
2. Initial Physical and Chemical Actions of 
Imparted Energy (including application to 
RBE and Quality Factors) 
3. Radiation Chemistry - General 
Concepts, Aqueous Systems, Ionization, 
excitation and formation of free radicals 
4. Initial reactions (including influence of 
LET, oxygen and various compounds on 
free radical forming reactions) and 
Factors Affecting Reactions 
5. Application to Dosimetry (including 
MIRD techniques) 
6. Cellular Response - Effect on Cells, 
Sensitive Organelles, Concept of Target(s) 
and Radiosensitivity, Response to 
Increasing Radiation Dose, Factors 
Influencing Response 
7. Effects on Nucleic Acids 
8. Radiation Genetics (Hereditary Effects) 
9. Effects of Ionizing Radiation on the 
Embryo and Foetus 
10. Whole-Body Effects of Ionizing 
Radiation 
11. Acute Effects of Ionizing Radiation 
12. Delayed Effects of Ionizing Radiation 
13. Low Level (Low Dose Exposure to 
Ionizing Radiation) 
14. Basic Principles of Radiotherapy  
To develop through 
understanding of basic radiation 
biology principles and their 
application to nuclear medicine 
and radiation protection. 
Advanced 
radiopharmaceutical 
chemistry 
Review of Current Radiopharmaceutical 
Chemistry research and future 
implications. 
Develop understanding of current 
radiopharmaceutical research 
and future directions. 
Imaging procedures, 
equipment quality 
control, associated 
radiation safety and 
image interpretations. 
Drug interventions and 
interactions/adverse 
Prepare/administer 
radiopharmaceuticals.  
2. Perform imaging and non-imaging 
nuclear medicine procedures.  
3. Demonstrate patient care tasks in the 
patient care course lab setting.  
4. Correlate different nuclear medicine 
procedures normal anatomy and 
Develop through understanding 
of principles of 
pharmacovigilance and 
underlying mechanisms of drug 
interactions with 
radiopharmaceuticals, altered 
bio-distributions, adverse 
reactions and the regulatory and 
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reactions abnormal pathology on a nuclear 
medicine image.  
5. Demonstrate radiation safety 
techniques to minimize radiation 
exposure.  
6. Demonstrate quality control 
procedures. 
7. Perform patient nuclear medicine 
procedures with appropriate 
radiopharmaceuticals. Identify normal 
and abnormal patterns of 
radiopharmaceutical distribution.  
8. Cite procedures, medications and 
possible adverse reactions for various 
nuclear medicine procedures. 
9. Specify equipment required for 
performing nuclear medicine procedures.  
10. Identify technical consideration for 
various nuclear medicine procedures.  
11. Registration of interaction and 
adverse reaction 
12. Pharmacovigilance in Radiopharmacy 
professional reporting 
mechanisms. 
Biopharmacy, 
radiotracer transport, 
pharmacokinetics, 
modelling  
1. Drug absorption- gastrointestinal: 
mechanisms, anatomical and 
physiological consideration of the GI 
tract- physico-Chemical, Physiological 
factors in drug absorption, Food-drug and 
Drug-drug interactions in drug 
absorption.  
2. Dosage form considerations in drug 
absorption-formulatory and 
manufacturing factors-Absorption of 
drugs from solutions and solid dosage 
forms-optimizing oral absorption, 
Biopharmaceutical considerations in drug 
product design.  
3. Bioavailability and bioequivalence of 
drug products- Factors-Assessment- 
Experimental designs and protocols for 
bioavailability and bioequivalence 
studies.  
4. Study of drug distribution, protein 
binding, metabolism and elimination of 
drugs-Kinetic considerations-clearance 
concepts-organ, total and renal clearance 
and excretion. 
Develop through understanding 
of pharmacokinetic modelling as 
applicable to 
radiopharmaceuticals. 
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5. Drug dissolution: dissolution of drugs 
from solid dosage forms-Factors and 
kinetics of dissolution- in vitro dissolution 
rate testing: Compendial methods, 
applications, models-correlation of in 
vitro and in vivo data.  
6. Pharmacokinetics: Rate process in 
biological systems-Transport of drugs: 
7. Mechanisms and kinetic 
considerations- compartment model-
Kinetic considerations of one and two-
Compartment models-Data analysis, i.v. 
and oral.  
8. Pharmacokinetic parameters: 
Biological half-life, Apparent volume of 
distribution, Clearance concepts, total 
body clearance, Rate constants for 
elimination, Absorption rate constants-
general considerations, methods of 
elimination, factors effecting, significance 
and use of the above parameters. 
Analysis of Blood and Urine data.  
9. Kinetics of multiple dosing-Dosage 
regimens-Loading and maintenance 
doses-Kinetics of sustained release and 
continuous blood levels. Kinetics of drug 
interactions.  
10. Multi-Compartmental models. 
Applications of Pharmacokinetic 
principles.  
Kit manufacturing for 
in-house, in-country 
and Global use 
Cold kit manufacturing for in-house use, 
national use or international use 
Develop detailed understanding 
of facility requirements, 
production methodologies and 
associated quality control for in-
house production of 
radiopharmaceutical cold kits. 
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Radioisotope 
production and 
Radiopharmaceutical 
preparation 
1. Definition of radiopharmaceuticals 
2. Compounding radiopharmaceuticals 
3. Essential components and additives, 
Conservation, Stability, Conditioning 
4. Formulation of radiopharmaceuticals- 
pharmaceuticals dosage forms: capsules, 
parenteral preparations, oral solutions, 
suspensions, gases and aerosols 
5. Pharmacovigilance 
6. Kits formulations 
7. 99m-Tc labelled radiopharmaceuticals 
8. Other diagnostic radiopharmaceuticals 
9. Radiolabeled blood cells as 
radiopharmaceuticals 
10. Positron emission 
radiopharmaceuticals 
11. Magistral preparations, Industrial 
radiopharmacy , centralized 
radiopharmacy 
To develop through 
understanding of compounding 
of radiopharmaceuticals from 
cold kits and manufacturing of 
radiopharmaceuticals from pre 
cursors through chemical 
synthesis, purification, 
formulation. 
To develop through 
understanding of blood cell 
radiolabeling procedures and 
associated quality control. 
Quality control (QC) of 
radiopharmaceuticals 
1. Introduction to the QC of 
radiopharmaceuticals 
2. QC for conventional 
radiopharmaceuticals 
3. QC for PET radiopharmaceuticals 
4. Principles of GLP 
5. Methods of validation 
6. Physical and chemical tests 
7. Biological tests 
8. Radiological tests 
9. QA in radiopharmacy 
To develop through 
understanding of Good 
laboratory practice, validation 
plan and methods, and quality 
control procedures as applicable 
to the compounding and 
manufacturing of 
radiopharmaceuticals. 
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Nuclear Medicine - 
aspects of clinical 
practice 
1. In vivo kinetics of radiopharmaceuticals 
- Absorption, distribution, metabolism, 
elimination 
2. Factors that affect/alter the kinetics of 
radiopharmaceuticals - Normal vs. 
abnormal kinetics 
3. Specific procedures that employ 
radiopharmaceuticals - Indications for the 
procedure, Criteria for the selection of 
the appropriate radiopharmaceutical, 
Optimal imaging or therapeutic protocols, 
Interventional techniques that enhance 
the procedure 
4. Interpretation of the procedure 
outcome and its effect on patient 
management- Sensitivity, specificity, and 
predictive value of diagnostic procedures 
5. Expected benefits of therapeutic 
procedures 
6. Preparation and monitoring of patients 
who receive radiopharmaceuticals 
7. Dosage adjustment based on age, 
weight, body surface area, organ 
function, instrument sensitivity, etc. 
8. Clinical problems associated with the 
use of radiopharmaceuticals - Adverse 
reactions / untoward effects, 
Misadministration / reportable events 
9. Unusual or unanticipated Images or 
therapeutic outcomes – Artifacts, Altered 
radiopharmaceutical bio-distribution due 
to interference from drug therapy or 
surgical Intervention, 
Radiopharmaceutical formulation 
problems, Improper administration 
techniques, Variations in human anatomy 
10. Correlation between the results of 
product quality control testing and 
clinical outcome of the procedure 
11. Use of radiopharmaceuticals to 
monitor the safety and/or efficacy of 
specific drug therapy regimens 
12. Drug information resources for 
nuclear medicine and nuclear pharmacy 
13. The role of the nuclear pharmacist as 
consultant and provider of patient 
specific Information. 
To develop detailed 
understanding of clinical nuclear 
medicine applications of 
radiopharmaceuticals. 
To develop through 
understanding of the role of a 
radiopharmacist in ensuring safe 
and efficacious use of 
radiopharmaceuticals in clinical 
practice. 
To develop through 
understanding of legal 
responsibilities of a 
radiopharmacist under applicable 
regulations. 
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Additional Theoretical 
Course - 1 
Communication skills To develop communication skills 
with own and other professional 
group and stakeholders. 
Additional Theoretical 
Course - 2 
Advanced design of SPECT and PET 
Radiopharmacy  
Be able to design SPECT, and PET 
Radiopharmacies as per the 
national and international 
applicable regulatory 
requirements. 
Good Manufacturing 
Practice 
1. Good Manufacturing Practice: 
definitions, requirements and historical 
background 
2. Quality assurance, quality 
management, design of quality systems 
3. Principles for documentation in GMP, 
Site Master File, SMF, Monographs 
4. Protocols (production protocols, 
standard operating procedures, SOP) 
5. Quality control, chemical and 
radiochemical identity and purity 
6. Risk analysis and risk assessment 
7. Clinical trials 
8. Qualification and validation 
9. Introduction to basic microbiology 
10. Microbiological test and quality 
control 
11. Aseptic production, localities, clothing 
12. Audit, monitoring, internal and 
external inspections 
13. Alternative quality systems (nationally 
and internationally) 
14. Good Manufacturing Practice in 
clinical trials 
15. Exercises; production of monographs 
and standard operation protocol, SOP, 
including exercise in aseptic production 
16. Requirements for radiolabeling of cell 
lines and proteins. 
Develop through understanding 
of GMP principles and practice so 
as to be able to plan and 
implement Good manufacturing 
practice in radiopharmacy. 
Be able to develop 
comprehensive list of Standard 
Operating procedures for 
implementation of Good 
Manufacturing Practice for 
clinical and research applications. 
Be able to plan and implement 
Pharmaceutical Quality system 
and complete cycle of internal 
quality audits. 
Regulations and Legal 
Aspects, Marketing 
Authorisations 
EU and FDA Radiopharmacy regulations  
Marketing authorisation process  
Compounding and manufacturing of 
radiopharmaceuticals  
Regulatory audits  
5. Regulatory inspections. 
Develop through understanding 
of regulatory requirements of 
radiopharmaceutical product 
registration process, 
compounding and manufacturing 
of radiopharmaceuticals. 
Develop through understanding 
of practical aspects of external 
audits and regulatory inspections 
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of radiopharmacy.  . 
Risk assessment Quality risk management principles and 
practical aspects applicable to 
radiopharmacy practice. 
Develop through understanding 
of Quality Risk management as 
applied to radiopharmacy. 
Validation facility, 
protocols, people 
Validation Master Plan 
Validation of facility and equipment and 
protocols 
3. Staff training, update and validation. 
Be able to develop and 
implement validation master 
plan. 
Radiopharmacy 
Management 
Management structure, responsibilities 
and governance. 
Develop understanding of 
different operational 
management structures of 
radiopharmacy service and 
responsibilities of key personnel. 
Quality Assurance and 
Product Performance 
1. Statistics 
2. Designing of experiments 
3. Statistical quality control 
4. Management of total quality 
5. Planning 
6. Documentation 
7. Audits 
8. Reliability 
9. Product safety 
10. Measurements and testing 
To develop through 
understanding of quality 
assurance and the associated 
statistical analysis. 
Blood cell labelling 
facilities and 
methodology 
1. Blood cell labelling facilities and safety 
precautions. 
2. Blood cell labelling techniques for red 
blood cells, white blood cells, platelets 
and stem cells. 
3. Quality control as applicable to blood 
cell labelling technique. 
Develop through understanding 
of facility and skill requirements 
for blood cell radiolabeling, 
Blood cell labelling 
clinical applications 
1. Clinical applications of radiolabeled red 
blood cells. 
2. Clinical applications of radiolabeled 
while blood cells. 
3. Clinical applications of radiolabeled 
platelets. 
4. Clinical applications of radiolabeled 
stem cells.   
Develop through understanding 
of clinical applications of 
radiolabeled blood elements. 
Radiopharmaceutical 
preparation - SPECT 
radiopharmaceuticals 
1. Orientation to Radiopharmacy Practice  
- daily routines and the functions, 
- procurement,  
- compounding,  
Develop through understanding 
of practical aspects of 
manufacturing of PET 
radiopharmaceuticals. 
E-Learning program and 
Learning Management 
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- quality control, dispensing and 
distribution of radiopharmaceuticals,  
- waste disposal and radiation safety 
procedures 
- routine functions for  the development 
and testing of new radiopharmaceuticals 
and formulations. 
- participate in the transport and delivery 
of radiopharmaceuticals  
- visit the professional staff at nuclear 
medicine departments serviced by the 
Radiopharmacy Unit 
2. Procurement of Radiopharmaceuticals 
- radioactive materials license 
- ordering radiopharmaceuticals 
- receipt of radiopharmaceuticals 
3. Compounding of Radiopharmaceuticals 
- Tc-99m generator operations 
- Tc-99m kits 
- to set up the compounding and 
dispensing areas with proper shielding 
barriers, absorbent coverings and 
materials 
- Laminar airflow hoods - proper setup, 
opening, and maintenance of hood for 
radiopharmaceutical procedures 
- Aseptic and safety techniques 
- Compounding procedures - preparing 
non-kit and specially-prepared 
radiopharmaceuticals such as labelled 
proteins, blood calls, monoclonal 
antibodies and specific chemical entities 
- Radiation measurement - GM survey 
meter, Dose calibrator, Scintillation well 
counter, Single vs. multichannel counters 
Radiopharmaceutical 
preparation - PET 
radiopharmaceuticals 
1. Orientation to Radiopharmacy Practice  
- daily routines and the functions, 
- procurement,  
- compounding,  
- quality control, dispensing and 
distribution of PET radiopharmaceuticals,  
- waste disposal and radiation safety 
procedures 
- routine functions for  the development 
and testing of new radiopharmaceuticals 
and formulations. 
- participate in the transport and delivery 
Develop through understanding 
of practical aspects of 
manufacturing of PET 
radiopharmaceuticals. 
E-Learning program and 
Learning Management 
System for post graduate 
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of radiopharmaceuticals  
- visit the professional staff at PET  
departments serviced by the PET 
Radiopharmacy Unit 
2. Principles of Positron Emission 
Tomography (PET) 
3. PET Camera: Coincidence Counting and 
Selection of Detectors, Nuclear Physics 
and Tomography module, Attenuation of 
Gamma Photons; Transmission Scanning 
and Attenuation Correction  
4. Positron-Emitting Nuclides  
5. Principles of Cyclotron 
Operation/Radionuclide Production  
6. Radioisotope Production module 
7. Synthesis & Applications of 15O-, 13N-, 
and 11C-Radiopharmaceuticals  
8. Synthesis & Applications of 18F-
Radiopharmaceuticals  
9. Synthesis & Applications of 18F-
fluorodeoxyglucose, Automation and 
Quality Control 
10. GC and HPLC as tools for purification 
and quality assurance 
11. Accepted Clinical Applications of PET 
– Neurology and Neurology case studies 
Oncology and Oncology Case Studies, 
Cardiology and Cardiology Case studies 
12. Quantitation of Physiological 
Parameters with PET: Tracer Kinetic 
Modelling 
13. Generator-Produced Radionuclides 
(82Rb, 68Ga, 62Cu) 
14. Regulatory Issues in PET (180-182) 
15. cGMP Standards for Clinical PET 
Radiopharmaceuticals 
E-Learning program and 
Learning Management 
System for post graduate 
training in Radiopharmacy 
Project: RAF6049 
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Radiopharmaceutical 
preparation - 
Therapeutic 
radiopharmaceuticals 
1. Orientation to Radiopharmacy Practice  
- daily routines and the functions, 
- procurement,  
- compounding,  
- quality control, dispensing and 
distribution of radiopharmaceuticals,  
- waste disposal and radiation safety 
procedures 
- routine functions for  the development 
and testing of new radiopharmaceuticals 
and formulations. 
- participate in the transport and delivery 
of radiopharmaceuticals  
- visit the professional staff at nuclear 
medicine departments serviced by the 
Radiopharmacy Unit 
2. Procurement of Radiopharmaceuticals 
- radioactive materials license 
- ordering radiopharmaceuticals 
- receipt of radiopharmaceuticals 
3. Compounding of Radiopharmaceuticals 
- to set up the compounding and 
dispensing areas with proper shielding 
barriers, absorbent coverings and 
materials 
- Laminar airflow hoods - proper setup, 
opening, and maintenance of hood for 
radiopharmaceutical procedures 
- Aseptic and safety techniques 
- Compounding procedures - preparing 
non-kit and specially-prepared 
radiopharmaceuticals such as labelled 
proteins, blood calls, monoclonal 
antibodies and specific chemical entities 
- Radiation measurement - GM survey 
meter, Dose calibrator, Scintillation well 
counter, Single vs. multichannel counters 
Develop through understanding 
of compounding and 
manufacturing of therapeutic 
radiopharmaceuticals. 
Operation of a GMP 
facility 
1. Principle of GMP and facility design 
(planning and validation) 
2. Quality assurance and quality 
management systems (including 
documentations) 
3.  Quality of the personnel  
4. Premises and equipment 
Develop through understanding 
of practical  details of setting up 
and operating GMP compliant 
radiopharmaceutical facilities as a 
single non commercial facility or 
as a commercial radiopharmacy 
service provider. 
E-Learning program and 
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Quality control of 
radiopharmaceuticals 
1. Radionuclidic purity – be able to 
quantitate purity using gamma 
scintillation spectrometry or shielding 
methods 
2. Radiochemical purity - be able to 
determine amount of radiochemical 
impurities - Thin layer chromatography, 
Solvent extraction, Column 
chromatography - low pressure and 
HPLC, Precipitation with filtration or 
centrifugation 
3. Pharmaceutical purity – pH, Visual 
inspection, Chemical tests, Cell viability, 
Antigen excess 
4. Instrument tests - Dose calibrator, G-M 
meter 
5. Perform tests at appropriate intervals 
and record results 
6. Equipment Tests - proper operation of 
laminar airflow hoods, exhaust hoods, 
centrifuges and balances through 
standard in house or independent 
laboratory test methods 
Develop through understanding 
of practical aspects of quality 
control instrumentation, 
calibrations and use for 
implementing 
radiopharmaceutical quality 
assurance. 
E-Learning program and 
Learning Management 
System for post graduate 
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Clinical application of 
radiopharmaceuticals 
/NM 
1. Diagnostic Imaging Procedures 
- Brain and cerebrospinal fluid 
- Endocrine organs (thyroid, parathyroid, 
adrenal glands) 
- Cardiovascular (including deep vein 
thrombosis) 
- Pulmonary (perfusion and ventilation 
studies) 
- RES (liver, spleen, bone marrow) 
- Hepatobiliary 
- Musculoskeletal 
- Genitourinary 
- Tumour/Abscess/Inflammatory 
processes 
- Gastrointestinal 
- Miscellaneous studies (e.g. 
lymphoscintigraphy) 
 
2. In Vivo Function Studies 
- Thyroid uptake 
- Blood related parameters (e.g., RBC 
mass, plasma volume and RBC survival) 
- Glomerular filtration rate (GFR) 
- Effective renal plasma flow (ERPF) 
- Miscellaneous 
 
3. Therapeutic Procedures 
- Hyperthyroidism and thyroid carcinoma 
- Polycythaemia Vera 
- Malignant effusions 
- Painful bone metastases 
- Radioimmunotherapy using 
radiolabelled monoclonal antibodies, 
peptides, or 
- molecular recognition units 
- Miscellaneous 
Develop through understanding 
of practical aspects of 
radiopharmaceutical use for 
diagnostic and therapeutic 
applications in clinical practice. 
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2 Applicable videos required to be produced on the practical aspects of radiopharmacy 
2.1 Practical aspects of radiation protection in all aspects of radiopharmacy (PET, SPECT, 
Therapeutic and Research applications) 
2.2 Practical aspects of clean room operations. 
2.3 Practical aspects of microbiological monitoring. 
2.4 Practical aspects of SPECT radiopharmacy and associated quality control procedures. 
2.5 Practical aspects of PET radiopharmacy and associated quality control. 
2.6 Practical aspects of therapeutic radiopharmaceuticals and quality control. 
2.7 Practical aspects of blood cell elements radiolabeling, associated quality control and special 
precautions. 
2.8 Practical aspects of Good Manufacturing Practice and associated self-audits in radiopharmacy. 
3 Applicable documents and websites 
3.1 Operational Guidance on Hospital Radiopharmacy: A Safe and Effective Approach 
IAEA publication 2008 PUB/1342; (ISBN:978-92-0-106708-1). 
3.2 Competency Based Hospital Radiopharmacy Training. Training Course Series No. 39.  
IAEA-TCS-39; Date Published: 2010 
3.3 Cyclotron Produced Radionuclides: Guidance on Facility Design and Production of 
Fluorodeoxyglucose 
(FDG) 
IAEA Radioisotopes and Radiopharmaceuticals Series No. 3.  
English STI/PUB/1515; (ISBN:978-92-0-117310-2): 2012. 
3.4 Strategies for Clinical Implementation and Quality Management of PET Tracers.  
IAEA/PUB/1344; (ISBN:978-92-0-107008-1),  2009 
3.5 Cyclotron Produced Radionuclides: Emerging Positron Emitters for Medical Applications: 64Cu 
and 124I. 
IAEA Radioisotopes and Radiopharmaceuticals Reports No. 1 
IAEA/PUB/1717; (ISBN:978-92-0-109615-9): 2016 
3.6 http://www.isorbe.com/index.php?pid=kat7 
3.7 http://www.eanm.org/publications/guidelines/radiopharmacy/ 
3.8 http://aphameeting.pharmacist.com/sites/default/files/slides/Loveless%20Updates%20on%2
0Radio%20Pharm%20Sat%20rm%20340handout_1.pdf 
3.9 https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidanc
es/UCM534811.pdf 
 
